Australia's largest stock trading and investment forum Australia's #1 stock forum

ACW

3.85%

2.7¢ actinogen medical limited

Under valued stock, page-81

First 81 Last

Share
Profile

Follow
Titans19

2,947 Posts.

1315

09/06/21

07:47

Post #: 53729426
Share

Originally posted by Wasabibarako: ↑

Rudder: "Alzheimer's is back on the radar...."

Rudder/others: What a great day indeed for ACW or any other company in the AD development field. Biogen's ADUCANUMAB (originally developed in Europe (Switzerland) many, many years ago and farmed out to Biogen a LONG time ago) makes world headlines, as it represents the first new ALZHEIMER's drug in almost 20 years that got FDA approval.

The really strange thing, however, is that the drug does not really seem to work! I quote from an article in "The Guardian" newspaper hereafter.

QUOTE:
"Amazingly, the FDA have sidestepped available clinical trial outcomes data that indicate the drug proably doesn't work.
The FDA rejected the application in November, when its members were split on the merits. Three of its advisers went public, writing in a scientific journal that there was not enough evidence that it worked. They were concerned that if the drug were approved largely because of the dearth of drugs for Alzheimer's, it would lower the bar for the future.
END OF QUOTE

This is an amazingly positive outcome for ACTINOGEN in my opinion. ACW's drug does not really have to work totally solidly as long as ACW can partner with a BIG PHARMA company in the USA that will have the right kind of connections with the FDA.

Obviously, personally I would - respectively hopefully WILL - see an outcome that shows that ACW's drug does in fact really work...

wasa

Expand

Maybe a big Pharma that was in the know with both SG, and what was happening with Biogen has been the accumulator for the last few months...?

ACW Price at posting: 16.0¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

What's causing the cost-of-living crisis, and how to navigate it

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins